APIS Assay Technologies provides end-to-end in vitro diagnostic (IVD) assay development services. With deep expertise and capabilities in infectious diseases, APIS can accelerate your route to market whether you are in early feasibility, development, or later verification and validation. In-house manufacturing minimises the burden of design transfer and regulatory, quality, and clinical teams working alongside our technical teams ensure assay compliance (UKCA, CE-IVDR, FDA). Our software team can build analysis pipelines and user-friendly reporting software, ultimately bringing more solutions to more people, to improve and save lives.